טוען...
Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
BACKGROUND: Hypocalcaemia is increasingly recognized as a complication of denosumab use in Chronic Kidney Disease (CKD) patients with osteoporosis. Despite Therapeutic Goods Administration (TGA) notifications in 2013, we have subsequently encountered several cases of denosumab-induced hypocalcaemia,...
שמור ב:
| הוצא לאור ב: | Case Rep Nephrol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6241374/ https://ncbi.nlm.nih.gov/pubmed/30519493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7384763 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|